1,352
Participants
Start Date
September 9, 2023
Primary Completion Date
June 1, 2025
Study Completion Date
June 1, 2025
First-line antihypertensive single-pill combination (SPC)
In intervention villages, participants diagnosed with aHT are offered pharmacological treatment (eHealth supported prescription of first-line antihypertensive single-pill combination (SPC)) and treatment monitoring in the villages by CC-VHWs guided by the ComBaCaL app.
Standardized counselling and referral to the closest health facility
In control villages, participants diagnosed with aHT receive a standardized counselling by the CC-VHW and are referred to the closest health facility for initiation or continuation of antihypertensive treatment.
University Hospital Basel, Division of Clinical Epidemiology, Basel
SolidarMed Lesotho, Maseru
Swiss Agency for Development and Cooperation (SDC)
UNKNOWN
World Diabetes Foundation (WDF)
UNKNOWN
University Hospital, Basel, Switzerland
OTHER